The global threat of counterfeit drugs: why industry and governments must communicate the dangers

PLoS Med. 2005 Apr;2(4):e100. doi: 10.1371/journal.pmed.0020100. Epub 2005 Mar 14.


The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Confidentiality
  • Drug Industry*
  • Economic Competition
  • Fraud*
  • Global Health
  • Government
  • Humans
  • Information Services*
  • Legislation, Drug
  • Patient Education as Topic
  • Security Measures